| Literature DB >> 22915665 |
Silvia Stringhini1, Adam G Tabak, Tasnime N Akbaraly, Séverine Sabia, Martin J Shipley, Michael G Marmot, Eric J Brunner, G David Batty, Pascal Bovet, Mika Kivimäki.
Abstract
OBJECTIVE: To assess the contribution of modifiable risk factors to social inequalities in the incidence of type 2 diabetes when these factors are measured at study baseline or repeatedly over follow-up and when long term exposure is accounted for.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22915665 PMCID: PMC3424226 DOI: 10.1136/bmj.e5452
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Study participants’ characteristics at phase 3 (baseline) and incidence of diabetes over 17.7 years of follow-up by socioeconomic status. Values are numbers (percentages) unless stated otherwise
| Socioeconomic status | P value* | All (n=7237) | |||
|---|---|---|---|---|---|
| High (n=2831; 39.1%) | Intermediate (n=3292; 45.5%) | Low (n=1114; 15.4%) | |||
| Incidence of type 2 diabetes† | 243 (5.6) | 407 (8.9) | 169 (10.9) | <0.001 | 818 (7.9) |
| Mean (SD) age (years) | 49.5 (5.8) | 48.8 (6.0) | 51.2 (6.0) | <0.001 | 49.4 (6.0) |
| Men | 2470 (87.3) | 2273 (69.1) | 298 (26.8) | <0.001 | 5041 (69.7) |
| White ethnic group | 2794 (98.7) | 2971 (90.3) | 833 (74.8) | <0.001 | 6598 (91.2) |
| Family history of type 2 diabetes | 246 (8.7) | 368 (11.2) | 172 (15.4) | <0.001 | 786 (10.9) |
| Smoking | 234 (7.4) | 485 (14.9) | 241 (22.4) | <0.001 | 960 (13.8) |
| Heavy drinking | 573 (18.7) | 505 (14.2) | 57 (9.8) | <0.001 | 1135 (14.9) |
| Unhealthy diet | 809 (24.9) | 1212 (35.2) | 396 (45.4) | <0.001 | 2417 (33.6) |
| Physical inactivity | 341 (14.4) | 612 (22.4) | 477 (30.3) | <0.001 | 1430 (21.2) |
| Obesity | 191 (7.9) | 295 (9.8) | 176 (11.8) | <0.001 | 662 (9.5) |
| High triglycerides (≥1.7 mmol/L) | 760 (23.0) | 862 (26.9) | 284 (30.9) | <0.001 | 1906 (26.3) |
| Low HDL cholesterol (<1.0/1.2 mmol/L in men/women) | 472 (15.1) | 629 (19.5) | 249 (24.0) | <0.001 | 1350 (18.9) |
| High systolic blood pressure (≥140 mm Hg) | 217 (7.5) | 252 (7.7) | 79 (7.9) | 0.72 | 548 (7.7) |
HDL=high density lipoprotein.
*For linear trend across socioeconomic categories.
†Age, sex, and ethnicity adjusted incidence rate per 1000 person years.
‡Age, sex, and ethnicity adjusted prevalence.
Association of health behaviours and other risk factors assessed at baseline (phase 3) with type 2 diabetes incidence (n=7237)
| Behaviour/risk factor | Hazard ratio* (95% CI) |
|---|---|
| Family history of type 2 diabetes (yes | 2.15 (1.82 to 2.55) |
| Smoking (yes | 1.47 (1.22 to 1.78) |
| Alcohol consumption: | |
| Abstainers (0 units/week) | 1.21 (1.02 to 1.44) |
| Heavy (≥21/14 units/week for men/women) | 1.04 (0.85 to 1.27) |
| Diet: | |
| Unhealthy | 1.36 (1.15 to 1.61) |
| Moderately healthy | 0.96 (0.81 to 1.15) |
| Physical activity: | |
| Inactive | 1.33 (1.13 to 1.56) |
| Moderately active | 1.25 (1.04 to 1.5) |
| Body mass index: | |
| Overweight (25-29 | 1.92 (1.64 to 2.25) |
| Obese (≥30 | 4.79 (3.96 to 5.80) |
| High triglycerides§ (yes | 2.98 (2.59 to 3.42) |
| Low high density lipoprotein cholesterol¶ (yes | 2.24 (1.93 to 2.59) |
| High systolic blood pressure** (yes | 1.86 (1.51 to 2.28) |
*Adjusted for age, sex, and ethnicity.
†1-21/1-14 units/week for men/women
‡Healthy=upper third of alternative healthy eating index (see Methods).
§≥1.7 mmol/L.
¶<1.0/1.2 mmol/L in men/women.
**≥140 mm Hg.
Contribution of baseline risk factors/markers (phase 3) in explaining social inequalities in type 2 diabetes incidence (n=7237)
| Baseline risk factors/markers | Hazard ratio (95% CI) | % difference* (95% CI) |
|---|---|---|
| Model 1†: lowest | 1.86 (1.48 to 2.32) | |
| Model 1 + smoking | 1.76 (1.40 to 2.21) | −9 (−47 to 22) |
| Model 1 + alcohol | 1.82 (1.45 to 2.29) | −3 (−32 to 32) |
| Model 1 + diet | 1.76 (1.40 to 2.21) | −8 (−44 to 22) |
| Model 1 + physical activity | 1.85 (1.47 to 2.32) | −1 (−37 to 29) |
| Model 2: model 1 + all health behaviours | 1.67 (1.32 to 2.10) | −17 (−58 to 15) |
| Model 1 + body mass index | 1.66 (1.32 to 2.08) | −18 (−57 to 15) |
| Model 3: model 2 (all health behaviours) + body mass index | 1.51 (1.19 to 1.91) | −33 (−78 to 1) |
| Model 3 + triglycerides | 1.40 (1.11 to 1.77) | −13‡ (−35 to 5) |
| Model 3 + high density lipoprotein cholesterol | 1.46 (1.16 to 1.85) | −5‡ (−12 to 1) |
| Model 3 + systolic blood pressure | 1.50 (1.19 to 1.91) | −1‡ (−15 to 8) |
| Model 4: all above risk factors | 1.40 (1.11 to 1.78) | −45 (−105 to −17) |
*Percentage attenuation in log HR=100×(βSES−βSES+risk factor(s))/(βSES), where β=log(HR).
†Adjusted for age, sex, ethnicity, and family history of type 2 diabetes.
‡Additional contribution of risk factor to model adjusted for all health behaviours and body mass index (model 3).
Contribution of repeatedly measured risk factors/markers in explaining social inequalities in type 2 diabetes incidence (n=7237)
| Model | Longitudinal assessment* | Longitudinal + long term assessment† | |||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | % difference‡ (95% CI) | Hazard ratio (95% CI) | % difference‡ (95% CI) | ||
| Model 1§: lowest | 1.86 (1.48 to 2.32) | 1.86 (1.48 to 2.32) | |||
| Model 1 + smoking | 1.80 (1.44 to 2.26) | −4 (−12 to 1) | 1.78 (1.42 to 2.23) | −7 (−16 to −2) | |
| Model 1 + alcohol | 1.84 (1.47 to 2.32) | −1 (−9 to 6) | 1.80 (1.43 to 2.26) | −5 (−14 to 2) | |
| Model 1 + diet | 1.77 (1.41 to 2.22) | −8 (−15 to −3) | 1.76 (1.40 to 2.21) | −8 (−16 to 3) | |
| Model 1 + physical activity | 1.79 (1.43 to 2.24) | −6 (−12 to −2) | 1.74 (1.39 to 2.19) | −10 (−19 to −4) | |
| Model 2: model 1 + all health behaviours | 1.69 (1.34 to 2.13) | −15 (−29 to −5) | 1.60 (1.26 to 2.02) | −24 (−43 to −11) | |
| Model 1 + body mass index | 1.62 (1.29 to 2.04) | −22 (−39 to −13) | 1.61 (1.28 to 2.02) | −23 (−41 to −13) | |
| Model 3: model 2 (all health behaviours) + body mass index | 1.48 (1.17 to 1.88) | −36 (−64 to −22) | 1.41 (1.11 to 1.78) | −45 (−75 to −28) | |
| Model 3 + triglycerides | 1.43 (1.13 to 1.81) | −6¶ (−13 to 2) | 1.35 (1.06 to 1.71) | −7¶ (−11 to 0) | |
| Model 3 + HDL cholesterol | 1.43 (1.13 to 1.81) | −5¶ (−12 to 2) | 1.37 (1.07 to 1.75) | −4¶ (−8 to 2) | |
| Model 3 + systolic blood pressure | 1.49 (1.18 to 1.89) | 1¶ (−1 to 2) | 1.42 (1.12 to 1.8) | 2¶ (−1 to 3) | |
| Model 4: all above risk factors | 1.41 (1.11 to 1.78) | −45 (−77 to −28) | 1.35 (1.05 to 1.72) | −53 (−88 to −29) | |
HDL=high density lipoprotein; SES=socioeconomic status.
*Adjustment for risk factors assessed at phases 3, 5, and 7.
†Risk factors updated at phases 3, 5, and 7 and additionally adjusted for risk factor at previous phase; cumulative exposure to high triglycerides not assessed for time period between phases 1 and 3, owing to lack of data at phase 1.
‡Percentage attenuation in log HR=100×(βSES−βSES+risk factor(s))/(βSES), where β=log(HR).
§Adjusted for age, sex, ethnicity, and family history of type 2 diabetes
¶Additional contribution of risk factor to model adjusted for all health behaviours and body mass index (model 3).